Ntv Asset Management LLC Bristol Myers Squibb CO Transaction History

Ntv Asset Management LLC

$883 Million
Q3 2025

A detailed history of Ntv Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ntv Asset Management LLC holds 26,055 shares of BMY stock, worth $1.22 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

26,055

Previous 30,244 13.85%

Holding current value

$1.22 Million

Previous $1.4 Million 16.01%

% of portfolio

0.13%

Previous 0.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	SELL	$43.31 - $48.98 $181,425 - $205,177	-4,189 Reduced 13.85%	26,055 $1.18 Million
Q2 2025 Jul 21, 2025	SELL	$44.12 - $59.6 $57,356 - $77,480	-1,300 Reduced 4.12%	30,244 $1.4 Million
Q1 2025 Apr 30, 2025	SELL	$53.9 - $63.11 $53,900 - $63,110	-1,000 Reduced 3.07%	31,544 $1.92 Million
Q4 2024 Jan 31, 2025	SELL	$51.92 - $59.94 $7,736 - $8,931	-149 Reduced 0.46%	32,544 $1.84 Million
Q3 2024 Oct 31, 2024	SELL	$39.66 - $51.75 $30,696 - $40,054	-774 Reduced 2.31%	32,693 $1.69 Million

Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $9,619 - $12,664	-239 Reduced 0.71%	33,467 $1.39 Million
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $138,374 - $156,889	2,884 Added 9.36%	33,706 $1.83 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $72,816 - $86,890	-1,502 Reduced 4.65%	30,822 $1.58 Million
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $75,257 - $84,149	-1,300 Reduced 3.87%	32,324 $1.88 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $20,544 - $24,327	300 Added 0.9%	33,624 $2.42 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $65 - $38,420	-500 Reduced 1.48%	33,324 $2.37 Million
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $53,230 - $58,625	733 Added 2.22%	33,824 $2.6 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $110,602 - $132,622	1,799 Added 5.75%	33,091 $2.42 Million
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $37,541 - $43,764	700 Added 2.29%	31,292 $1.95 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $29,585 - $34,655	500 Added 1.66%	30,592 $1.81 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $21,668 - $23,597	-350 Reduced 1.15%	30,092 $2.01 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $42,546 - $47,852	717 Added 2.41%	30,442 $1.92 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $34,644 - $39,258	-600 Reduced 1.98%	29,725 $1.84 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.33%	30,325 $1.83 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $93,194 - $108,953	1,700 Added 5.92%	30,425 $1.79 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $15,868 - $23,061	-342 Reduced 1.18%	28,725 $1.6 Million
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $34,447 - $44,933	700 Added 2.47%	29,067 $1.87 Million
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $51,324 - $60,852	-1,200 Reduced 4.06%	28,367 $1.44 Million
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $69,161 - $76,477	-1,550 Reduced 4.98%	29,567 $1.34 Million
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $13,536 - $16,140	300 Added 0.97%	31,117 $1.49 Million
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $95,082 - $123,298	-1,950 Reduced 5.95%	30,817 $1.6 Million
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $116,219 - $144,854	-2,300 Reduced 6.56%	32,767 $1.81 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $23,968 - $27,592	-400 Reduced 1.13%	35,067 $2.22 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $11,988 - $13,069	-200 Reduced 0.56%	35,467 $2.17 Million
Q3 2017 Nov 06, 2017	SELL	$55.23 - $63.74 $63,514 - $73,301	-1,150 Reduced 3.12%	35,667 $2.27 Million
Q2 2017 Aug 08, 2017	BUY	N/A	36,817	36,817 $2.05 Million

Others Institutions Holding BMY

# of Institutions

2,683

Shares Held

1.58B

Call Options Held

28.2M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.

Account

Ntv Asset Management LLC Bristol Myers Squibb CO Transaction History